Gensaic
Gensaic is focused on decoding the language of delivery for metabolic health by developing next-generation metabolic medicines. They utilize AI-enabled protein design and unbiased discovery of protein sequences to enable intracellular delivery to target tissues, cells, and organelles. Their mission involves creating potent, selective, and safe medicines for a broad range of metabolic indications, leveraging their FORGE™ platform for protein evolution and design.
Industries
Nr. of Employees
small (1-50)
Products
Platform for functional optimization via recursive genetic evolution
A discovery platform that combines recursive genetic evolution with AI-guided generative protein design and large-scale screening to identify and optimize protein delivery vehicles with tissue and cellular selectivity.
Platform for functional optimization via recursive genetic evolution
A discovery platform that combines recursive genetic evolution with AI-guided generative protein design and large-scale screening to identify and optimize protein delivery vehicles with tissue and cellular selectivity.
Services
Discovery collaborations and licensing for tissue-selective delivery
Partnered research and licensing engagements to apply protein-design and screening capabilities toward discovery of tissue-selective delivery ligands and preclinical development candidates.
Discovery collaborations and licensing for tissue-selective delivery
Partnered research and licensing engagements to apply protein-design and screening capabilities toward discovery of tissue-selective delivery ligands and preclinical development candidates.
Expertise Areas
- Protein engineering and design
- Intracellular delivery and tissue targeting
- Generative AI for protein design
- High-throughput directed evolution
Key Technologies
- Generative protein design
- Machine learning / AI for protein engineering
- Directed evolution / recursive genetic evolution
- Billion-scale sequence screening